Insmed Incorporated To Participate At February Investment Conferences

Insmed Incorporated (Nasdaq:INSM) today announced that Company management will participate at the following investor conferences in February:

•Canaccord Genuity’s Rare Disease Biopharma Day on February 3, 2015 in New York City; and

•2015 Leerink Global Healthcare Conference taking place in New York City on February 11-12, 2015. Will Lewis, President and Chief Executive Officer of Insmed, will participate in a fireside chat with Leerink Partners’ analyst, Joseph Schwartz, on February 11, 2015 at 11:30 a.m. Eastern time.

Help employers find you! Check out all the jobs and post your resume.

Back to news